{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:30:21Z","timestamp":1773657021419,"version":"3.50.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[1998,1]]},"DOI":"10.1016\/s0006-2952(97)00214-1","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T14:51:33Z","timestamp":1027608693000},"page":"9-19","source":"Crossref","is-referenced-by-count":91,"title":["Antisense oligonucleotides: Is the glass half full or half empty?"],"prefix":"10.1016","volume":"55","author":[{"given":"C.Frank","family":"Bennett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0006-2952(97)00214-1_BIB1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1146\/annurev.pa.32.040192.001553","article-title":"Therapeutic applications of oligonucleotides","volume":"32","author":"Crooke","year":"1992","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1126\/science.8351515","article-title":"Antisense oligonucleotides as therapeutic agents-Is the bullet really magical?","volume":"261","author":"Stein","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.pa.36.040196.000543","article-title":"Progress in antisense oligonucleotide therapeutics","volume":"36","author":"Crooke","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/bies.950171210","article-title":"The therapeutic potential of antisense oligonucleotides","volume":"17","author":"Sharma","year":"1995","journal-title":"Bioessays"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1089\/ard.1994.4.67","article-title":"Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides","volume":"4","author":"Stein","year":"1994","journal-title":"Antisense Res Dev"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nm1195-1119","article-title":"Does antisense exist?","volume":"1","author":"Stein","year":"1995","journal-title":"Nature Med"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1126\/science.165.3898.1137","article-title":"Interferon induction increased through chemical modification of synthetic polyribonucleotide","volume":"165","author":"De Clercq","year":"1969","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB8","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1021\/bi00769a002","article-title":"Stereochemistry of the transesterification step of ribonuclease T1","volume":"11","author":"Eckstein","year":"1972","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB9","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1021\/ja01040a043","article-title":"Protecting groups for nucleosides used in synthesizing oligonucleotides","volume":"91","author":"Letsinger","year":"1969","journal-title":"J Am Chem Soc"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB10","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1021\/bi00590a017","article-title":"Nonionic nucleic acid analogues. Synthesis and characterization of dideoxyribonucleoside methylphosphonates","volume":"18","author":"Miller","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB11","first-page":"1537","article-title":"Selective inhibition of Escherichia coli protein synthesis and growth by nonionic oligonucleotides complementary to the 3\u2032 end of 16S rRNA","volume":"78","author":"Jayaraman","year":"1981"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0006-291X(89)91719-1","article-title":"Comparative activity of \u03b1- and \u03b2-anomeric oligonucleotides on rabbit \u03b2 globin synthesis: Inhibitory effect of cap targeted \u03b1-oligonucleotides","volume":"164","author":"Bertrand","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB13","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.7681216","article-title":"Phosphorodithioate DNA as a potential therapeutic drug","volume":"259","author":"Marshall","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB14","first-page":"7747","article-title":"2\u2032-O-Alkyl oligoribonucleotides as antisense probes","volume":"87","author":"Iribarren","year":"1990"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB15","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2533\/chimia.1996.168","article-title":"Second generation of antisense oligonucleotides: From nuclease resistance to biological efficacy in animals","volume":"50","author":"Altmann","year":"1996","journal-title":"Chimia"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB16","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1093\/nar\/23.11.2019","article-title":"Characterization of fully 2\u2032-modified oligoribonucleotide hetero- and homoduplex hybridization and nuclease sensitivity","volume":"23","author":"Cummins","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/nar\/24.3.411","article-title":"Enhanced activity of an antisense oligonucleotide targeting murine protein kinase C-\u03b1 by the incorporation of 2\u2032-O-propyl modifications","volume":"24","author":"McKay","year":"1996","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/ard.1995.5.3","article-title":"(2\u2032-5\u2032)-Oligo-3\u2032-deoxynucleotides: Selective binding to single-stranded RNA but not DNA","volume":"5","author":"Alul","year":"1995","journal-title":"Antisense Res Dev"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0960-894X(00)80412-6","article-title":"Synthesis and incorporation of methyleneoxyl (methylimino) linked thymidine dimer into antisense oligonucleotides","volume":"2","author":"Debart","year":"1992","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB20","doi-asserted-by":"crossref","first-page":"7767","DOI":"10.1021\/ja00020a052","article-title":"Deoxyoligonucleotides bearing neutral analogues of phosphodiester linkages recognize duplex DNA via triple-helix formation","volume":"113","author":"Matteucci","year":"1991","journal-title":"J Am Chem Soc"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB21","first-page":"5798","article-title":"Oligonucleotide N3\u2032 \u2192 P5\u2032 phosphoramidates","volume":"92","author":"Gryaznov","year":"1995"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB22","series-title":"Carbohydrate Modifications in Antisense Research","first-page":"24","article-title":"Novel backbone replacements for oligonucleotides","author":"De Mesmaeker","year":"1994"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1962210","article-title":"Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide","volume":"254","author":"Nielsen","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB24","doi-asserted-by":"crossref","first-page":"16416","DOI":"10.1016\/S0021-9258(17)34023-1","article-title":"Inhibition of protein kinase C-\u03b1 expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters","volume":"269","author":"Dean","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB25","doi-asserted-by":"crossref","first-page":"1453314540","DOI":"10.1074\/jbc.271.24.14533","article-title":"Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras","volume":"271","author":"Monia","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB26","first-page":"923","article-title":"Pharmacokinetic properties of several novel oligonucleotide analogs in mice","volume":"277","author":"Crooke","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB27","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0006-2952(95)00010-W","article-title":"Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1","volume":"49","author":"Zhang","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB28","first-page":"1181","article-title":"Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats","volume":"267","author":"Cossum","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB29","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0006-2952(95)00159-W","article-title":"In vivo stability, disposition and metabolism of a \u201chybrid\u201d oligonucleotide phosphorothioate in rats","volume":"50","author":"Zhang","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB30","first-page":"971","article-title":"Pharmacokinetics and tissue distribution of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration","volume":"278","author":"Zhang","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB31","first-page":"7595","article-title":"Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice","volume":"88","author":"Agrawal","year":"1991"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB32","first-page":"89","article-title":"Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats","volume":"269","author":"Cossum","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB33","first-page":"932","article-title":"Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate","volume":"45","author":"Sands","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jcla.1860090210","article-title":"Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides","volume":"9","author":"Srinivasan","year":"1995","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB35","first-page":"124","article-title":"Cell and tissue distribution of synthetic oligonucleotides in healthy and tumor-bearing nude mice","volume":"147","author":"Plenat","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB36","first-page":"717","article-title":"Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice","volume":"149","author":"Rifai","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB37","unstructured":"Butler M, Stecker K and Bennett CF, Histological localization of phosphorothioate oligodeoxynucleotides in normai rodent tissue. Nucleosides Nucleotides, in press."},{"key":"10.1016\/S0006-2952(97)00214-1_BIB38","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/ki.1995.406","article-title":"Renal uptake of an 18-mer phosphorothioate oligonucleotide","volume":"48","author":"Oberbauer","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB39","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1093\/nar\/19.20.5543","article-title":"Mechanism of cellular uptake of modified oligodeoxynucleotides containing methylphosphonate linkages","volume":"19","author":"Shoji","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB40","first-page":"3474","article-title":"Characterization of oligonucleotide transport into living cells","volume":"86","author":"Loke","year":"1989"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB41","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1021\/bi00069a022","article-title":"Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells","volume":"32","author":"Stein","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB42","first-page":"1023","article-title":"Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides","volume":"41","author":"Bennett","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB43","first-page":"843","article-title":"Calcium dependent cellular uptake of a c-myc antisense oligonucleotide","volume":"40","author":"Wu-Pong","year":"1994","journal-title":"Cell Mol Biol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB44","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/1523-1747.ep12396876","article-title":"Cationic lipid is not required for uptake and selective inhibitory activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes","volume":"103","author":"Nestle","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB45","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/1523-1747.ep12371683","article-title":"Characteristics of oligonucleotide uptake in human keratinocyte cultures","volume":"101","author":"Noonberg","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB46","first-page":"462","article-title":"In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides","volume":"275","author":"Crooke","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB47","first-page":"11762","article-title":"Inhibition of protein kinase C-\u03b1 expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides","volume":"91","author":"Dean","year":"1994"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB48","first-page":"236","article-title":"Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-\u03b1 phosphorothioate oligodeoxynucleotide","volume":"50","author":"Yazaki","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB49","first-page":"3499","article-title":"Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-a expression","volume":"56","author":"Dean","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB50","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nm0696-668","article-title":"Antitumor activity of a phosphorothioate oligodeoxynucleotide targeted against C-raf kinase","volume":"2","author":"Monia","year":"1995","journal-title":"Nature Med"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB51","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1172\/JCI118679","article-title":"The role of the intercellular adhesion molecule-1 (ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice","volume":"97","author":"Kumasaka","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB52","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nm0695-528","article-title":"A single-injection protein kinase A-directed antisense treatment to inhibit tumor growth","volume":"1","author":"Nesterova","year":"1995","journal-title":"Nature Med"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB53","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm0996-998","article-title":"Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-KB abrogates established experimental colitis in mice","volume":"2","author":"Neurath","year":"1996","journal-title":"Nature Med"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB54","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1172\/JCI118681","article-title":"In vivo targeting of inducible NO synthase with oligodeoxynucleotides protects rat kidney against ischemia","volume":"97","author":"Noiri","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB55","first-page":"631","article-title":"Experimental production and modulation of human cytotoxic dermatitis in human-murine chimeras","volume":"150","author":"Christofidou-Solomidou","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB56","first-page":"988","article-title":"An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodiutn-induced colitis in mice","volume":"280","author":"Bennett","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB57","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0167-4781(90)90031-V","article-title":"Specific regulation of gene expression by antisense, sense and antigene nucleic acids","volume":"1049","author":"Helene","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1054-3589(08)60492-5","article-title":"Regulation of endothelial cell adhesion molecule expression with antisense oligonucleotides","volume":"28","author":"Bennett","year":"1994","journal-title":"Adv Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB59","series-title":"Therapeutic Applications of Oligonucleotides","author":"Crooke","year":"1995"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0006-2952(95)02220-1","article-title":"Reduction of expression of the multidrug resistance protein, MRP, in human tumor cells by antisense phosphorothioate oligonucleotides","volume":"51","author":"Stewart","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB61","doi-asserted-by":"crossref","first-page":"30398","DOI":"10.1074\/jbc.271.48.30398","article-title":"Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells","volume":"271","author":"Condon","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/ard.1995.5.23","article-title":"Detection of ribonuclease H-generated mRNA fragments in human leukemia cells following reversible membrane permeabilization in the presence of antisense oligodeoxynucleotides","volume":"5","author":"Giles","year":"1995","journal-title":"Antisense Res Dev"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB63","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1016\/S0021-9258(18)55250-9","article-title":"Antisense oligonucleotides inhibit intercellular adhesion molecule l expression by two distinct mechanisms","volume":"266","author":"Chiang","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB64","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1016\/S0021-9258(19)85268-7","article-title":"Evaluation of 2\u2032-modified oligonucleotides containing 2\u2032deoxy gaps as antisense inhibitors of gene expression","volume":"268","author":"Monia","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB65","first-page":"1300","article-title":"Targeting RNA for degradation with a (2\u2032-5\u2032) oligoadenylate-antisense chimera","volume":"90","author":"Torrence","year":"1993"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB66","first-page":"1936","article-title":"Synthetic polynucleotides and the amino acid code","volume":"47","author":"Lengyel","year":"1961"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB67","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1074\/jbc.272.18.11994","article-title":"2\u2032-O-(2-Methoxy)ethyl modified anti-ICAM-1 oligonucleotides selectively increase the ICAM-1 mRNA Ievel and inhibit formation of the ICAM-1 translation initiation complex in HUVECs","volume":"272","author":"Baker","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB68","first-page":"12840","article-title":"Repair of thalassemic human \u03b2-globin mRNA in mammalian cells by antisense oligonucleotides","volume":"93","author":"Sierakowska","year":"1996"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB69","first-page":"905","article-title":"Inhibition of splicing of wild-type and mutated luciferase-adenovirus pre-mRNA by antisense oligonucleotides","volume":"48","author":"Hodges","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB70","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.4049\/jimmunol.152.7.3530","article-title":"Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides","volume":"152","author":"Bennett","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB71","doi-asserted-by":"crossref","first-page":"19954","DOI":"10.1016\/S0021-9258(19)88650-7","article-title":"Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides","volume":"267","author":"Monia","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB72","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nm0696-668","article-title":"Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase","volume":"2","author":"Monia","year":"1996","journal-title":"Nature Med"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB73","first-page":"15481","article-title":"Sequence-Specific antitumor activity of a phosphorothioate oligodeoxyribonucleotide targeted to human C-raf kinase supports an antisense mechanism of action in vivo","volume":"93","author":"Monia","year":"1996"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB74","doi-asserted-by":"crossref","first-page":"21875","DOI":"10.1016\/S0021-9258(20)80622-X","article-title":"Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells","volume":"268","author":"Barbour","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB75","first-page":"7","article-title":"Use of an antisense oligonucleotide to inhibit expression of a mutated human procollagen gene (COL1A1) in transfected mouse 3T3 cells","volume":"32","author":"Colige","year":"1993"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB76","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.7684856","article-title":"Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines","volume":"260","author":"Wagner","year":"1993","journal-title":"Science"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB77","doi-asserted-by":"crossref","first-page":"83918398","DOI":"10.1021\/bi00194a002","article-title":"Inhibition of human immunodeficiency virus type-l env expression by C-5 propyne oligonucleotides specific for rev-response element stem-loop V","volume":"33","author":"Fenster","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB78","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1074\/jbc.270.13.7161","article-title":"Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides","volume":"270","author":"Duff","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB79","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nbt0796-840","article-title":"Potent and selective inhibition of gene expression by an antisense heptanucleotide","volume":"14","author":"Wagner","year":"1996","journal-title":"Nature Biotech"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02172105","article-title":"Structural modifications toward improved antisense oligonucleotides","volume":"4","author":"Matteucci","year":"1996","journal-title":"Perspect Drug Dis Des"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB81","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1021\/jm00059a007","article-title":"Uniformly modified 2\u2032-deoxy-2\u2032-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets","volume":"36","author":"Kawasaki","year":"1993","journal-title":"J Med Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB82","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0092-8674(89)90036-6","article-title":"Antisense probing of the human U4\/U6 snRNP with biotinylated 2\u2032-OMe RNA oligonucleotides","volume":"59","author":"Blencowe","year":"1989","journal-title":"Cell"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB83","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/bi00081a031","article-title":"Oligodeoxynucleotides containing 2\u2032-O-modified adenosine: Synthesis and effects on stability of DNA:RNA duplexes","volume":"32","author":"Lesnik","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB84","series-title":"Antisense Research and Applications","first-page":"273","article-title":"Heterocyclic base modifications in nucleic acids and their applications in antisense oligonucleotides","author":"Sanghvi","year":"1993"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB85","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0040-4039(00)76514-2","article-title":"Remarkable enhancement of binding affinity of heterocyclemodified DNA to DNA and RNA. Synthesis, characterization and biophysical evaluation of N2-imidazolylpropylguanine and N2-imidazolylpropyl-2-aminoadenine modified oligonucleotides","volume":"35","author":"Ramasamy","year":"1994","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB86","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1021\/bi960626v","article-title":"Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents","volume":"35","author":"Kutyavin","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB87","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1021\/jo00063a014","article-title":"Synthesis and binding properties of pyrimidine oligodeoxynucleoside analogs containing neutral phosphodiester replacements. The formacetal and 3\u2032-thioformacetal internucleoside linkages","volume":"58","author":"Jones","year":"1993","journal-title":"J Org Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB88","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1021\/ja00036a076","article-title":"Oligonucleosides: Synthesis of a novel methylhydroxylaminelinked nucleoside dimer and its incorporation into antisense sequences","volume":"114","author":"Vasseur","year":"1992","journal-title":"J Am Chem Soc"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB89","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/anie.199402261","article-title":"Amides as a new type of backbone modification in oligonucleotides","volume":"33","author":"De Mesmaeker","year":"1994","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB90","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/anie.199210081","article-title":"Peptide nucleic acids (PNAs)Unusual properties of nonionic oligonucleotide analogues","volume":"31","author":"Meier","year":"1992","journal-title":"Angew Chem Int Edn"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB91","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/365566a0","article-title":"PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules","volume":"365","author":"Egholm","year":"1993","journal-title":"Nature"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB92","series-title":"Oligonucleotides: Antisense Inhibitors of Gene Expression","first-page":"137","article-title":"Control of gene expression by oligonucleotides covalently linked to intercalating agents and nucleic acid-cleaving reagents","author":"Helene","year":"1989"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB93","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0003-9861(88)90652-2","article-title":"Inhibition of rabbit \u03b2-globin synthesis by complementary oligonucleotides: Identification of mRNA sites sensitive to inhibition","volume":"263","author":"Goodchild","year":"1988","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB94","first-page":"13","article-title":"Walking along human c-myc mRNA with antisense oligodeoxynucleotides: Maximum efficacy at the 5\u2032 cap region","volume":"6","author":"Bacon","year":"1991","journal-title":"Oncogene Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB95","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1074\/jbc.272.1.626","article-title":"Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity","volume":"272","author":"Lima","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB96","doi-asserted-by":"crossref","first-page":"12055","DOI":"10.1021\/bi00163a013","article-title":"Implication of RNA structure on antisense oligonucleotide hybridization kinetics","volume":"31","author":"Lima","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB97","first-page":"223","article-title":"Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: Implications for antisense technology","volume":"41","author":"Gao","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB98","first-page":"5957","article-title":"Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides","volume":"91","author":"Perez","year":"1994"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB99","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1074\/jbc.270.6.2620","article-title":"Phosphorothioate oligodeoxynucleotides bind to basie fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix","volume":"270","author":"Guvakova","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB100","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/nar\/22.15.3202","article-title":"Sequence specific inhibition of human type II phospholipase A2 enzyme activity by phosphorothioate oligonucleotides","volume":"22","author":"Bennett","year":"1994","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB101","first-page":"4051","article-title":"The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism","volume":"92","author":"Burgess","year":"1995"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB102","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB103","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/355564a0","article-title":"Selection of single-stranded DNA molecules that bind and inhibit human thrombin","volume":"355","author":"Bock","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB104","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/355850a0","article-title":"Selection in vitro of singlestranded DNA molecules that fold into specific ligandbinding structures","volume":"355","author":"Ellington","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0960-9822(00)00093-2","article-title":"Aptamers achieve the desired recognition","volume":"4","author":"Ellington","year":"1994","journal-title":"Curr Biol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB106","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1093\/nar\/23.21.4239","article-title":"Binding of phosphorothioate oligodeoxynucleotides to basie fibroblast growth factor, recombinant soluble CD4, laminin and fibronectin is P-chirality independent","volume":"23","author":"Benimetskaya","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB107","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0167-7799(96)20006-X","article-title":"Phosphorothioate antisense oligodeoxynucleotides: Questions of specificity","volume":"14","author":"Stein","year":"1996","journal-title":"Trends Biotechnol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB108","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/nar\/23.7.1146","article-title":"Sequence context of antisense RelA\/NF-\u03baB phosphorothioates determines specificity","volume":"23","author":"Maltese","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB109","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0959-440X(05)80106-X","article-title":"Guanine quartets","volume":"3","author":"Williamson","year":"1993","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB110","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","article-title":"Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA","volume":"157","author":"Ballas","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB111","first-page":"421","article-title":"Immune stimulation-A class effect of phosphorothioate oligonucleotides in rodents","volume":"12","author":"Monteith","year":"1997","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB112","doi-asserted-by":"crossref","unstructured":"Levin AA, Monteith DK, Leeds JM, Nicklin PL, Geary RS, Butler M, Templin MV and Henry SP, Toxicity of oligodeoxynucleotide therapeutic agents. In: Antisense Research and Applications (Ed. Crooke ST). Springer, Heidelberg, in press.","DOI":"10.1007\/978-3-642-58785-6_5"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB113","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.1990.tb17838.x","article-title":"Large-scale economic synthesis of antisense phosphorothioate analogues of DNA for preclinical investigations","volume":"616","author":"Geiser","year":"1990","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB114","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0006-2952(95)00160-2","article-title":"Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration","volume":"50","author":"Agrawal","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB115","first-page":"6553","article-title":"Cholesteryl-conjugated oligonucleotides: Synthesis, properties, and activity as inhibitors of replication of human immunodeficiency virus in cell culture","volume":"86","author":"Letsinger","year":"1989"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB116","first-page":"808","article-title":"Inhibition of expression of the multidrug resistance-associated P-glycoprotein by phosphorothioate and 5\u2032-cholesterol-conjugated phosphorothioate antisense oligonucleotides","volume":"50","author":"Alahari","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB117","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0168-3659(96)01362-4","article-title":"Pharmacokinetics in mice of a [3H]labeled phosphorothioate oligonucleotide formulated in the presence and absence of a cationic lipid","volume":"41","author":"Bennett","year":"1996","journal-title":"J Control Rel"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB118","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/elps.11501601256","article-title":"DNA fingerprinting by hybridization to oligonucleotide arrays","volume":"16","author":"Southern","year":"1995","journal-title":"Electrophoresis"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB119","first-page":"383","article-title":"Antisense oligonucleotide inhibitors for the treatment of cancer: l) Pharmacokinetic properties of phosphorothioate oligodeoxynucleotides","volume":"12","author":"Geary","year":"1997","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB120","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0006-2952(95)02177-9","article-title":"Effect of different chemically modified oligodeoxynucleotides on immune stimulation","volume":"51","author":"Zhao","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB121","doi-asserted-by":"crossref","unstructured":"Boggs RT, McGraw K, Condon T, Flournoy S, Villiet P, Bennett CF and Monia BP, Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev, in press.","DOI":"10.1089\/oli.1.1997.7.461"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB122","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/ard.1995.5.131","article-title":"Characterization of binding sites, extent of binding, and drug interactions of oligonucleotides with albumin","volume":"5","author":"Kumar","year":"1995","journal-title":"Antisense Res Dev"},{"key":"10.1016\/S0006-2952(97)00214-1_BIB123","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1080\/15257779508014667","article-title":"Preparation of oligomeric 2\u2032-deoxy5-fluorouridylate of defined length and backbone composition: A novel pro-drug form of the potent anti-cancer drug 2\u2032-deoxy-5-fluorouridylate","volume":"14","author":"Gmeiner","year":"1995","journal-title":"Nucleosides Nucleotides"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295297002141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295297002141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,9]],"date-time":"2023-04-09T11:53:29Z","timestamp":1681041209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295297002141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["S0006295297002141"],"URL":"https:\/\/doi.org\/10.1016\/s0006-2952(97)00214-1","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}